[
  {
    "title": "Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications",
    "url": "https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: 42% improvement in data quality achieved through interactive web-based platform."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [SHIP NOW]**: Integrate daily check-ins to maintain engagement and completeness."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: New FDA guidelines mandate PRO integration by Q3 2025, creating immediate competitive pressure."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Data gaps across different PRO tools may limit interoperability and clinical utility."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC",
    "url": "https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: Patient-reported outcomes predict all-cause mortality and HF hospitalization in ATTR-CM."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [ROADMAP]**: Integrate AI-driven ePRO platforms to enhance data quality and compliance rates."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: FDA prioritizing PROs for FDA approval pathways, emphasizing clinical validity."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias in trials may underrepresent severe cases, impacting external validity."
      }
    ],
    "model": "granite4:tiny-h"
  },
  {
    "title": "Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer",
    "url": "https://ascopubs.org/doi/10.1200/OA-25-00051",
    "summary": [
      {
        "type": "bullet",
        "text": "**KEY FINDING**: 67% of patients completed assessments, reducing discontinuation risk by 30%, enhancing clinical trial data quality."
      },
      {
        "type": "bullet",
        "text": "**TACTICAL WIN [SHIP NOW]**: Implement automated ePRO reminders at key intervals to improve patient engagement and compliance."
      },
      {
        "type": "bullet",
        "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: Upcoming FDA regulations may require PRO integration in trials, emphasizing the need for robust ePRO solutions now."
      },
      {
        "type": "bullet",
        "text": "**CONCERN**: Self-selection bias could skew results toward healthier patients, potentially affecting the clinical validity of PROs."
      }
    ],
    "model": "granite4:tiny-h"
  }
]